Bluejay Diagnostics Inc (BJDX) Stock Price, Quote & News

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices

Sector: Healthcare

Phone: 844 327 7078

Website: bluejaydx.com

Address:

360 Massachusetts Avenue, Suite 203, Acton, United States

RichJunkie25 Sep. 1 at 7:06 PM

$CMND $GP $BJDX The latest Tammy casualties. Just remember it’s ok to follow Tammy but once that pumped stock is up 10% take the money and RUN! Do not hold. Do not hold out for larger gains. Take the quick small win and exit before you left holding the bag.

1 · Reply

the_viking Sep. 1 at 3:28 PM

$BJDX this stock is shorted by 1.19% .... you´re shure about your statement?!

0 · Reply

AtariLynx Aug. 31 at 3:24 PM

$BJDX if it will back to .83 I will add

0 · Reply

Funmoney2 Aug. 31 at 3:07 PM

$BJDX short sellers doing what they can to get rid of their shares and drop the price. Do not panic and do not sell. All a game.. just sit on them and hold

0 · Reply

AtariLynx Aug. 31 at 2:50 PM

$BJDX later

0 · Reply

dogood Aug. 31 at 11:03 AM

$BJDX let’s hit $1.5 today

0 · Reply

xTheEi8htx Aug. 31 at 12:47 AM

Ei8ht Watchlist Next Premarket 7:00–9:00 AM ET $NCT $BRNX $BJDX $NUWE $AEMD

0 · Reply

Ron_Burn Aug. 30 at 8:05 PM

$BJDX the 200-D MA is at 19, fuck it im throwing a 100$ on this tomorrow

0 · Reply

Xen_TorpedoCapital Aug. 30 at 10:10 AM

Top low float watch for Monday $BJDX (PP) $PAVS (BODN) $ERNA (EXP_X) $BSAA (EXP_Y) $NCEW (CON_Y EAP10D 100%+) PFSA (CON_X EAP10D 100%+)

1 · Reply

AtariLynx Aug. 29 at 7:05 AM

$BJDX not new but for those who think this is a scam company or just a pump and dump stock: https://ir.bluejaydx.com/news-releases/news-release-details/bluejay-diagnostics-reports-q2-2026-results-strengthened-balance

0 · Reply

Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization

2026-07-21T10:35:18.000Z - 6 weeks ago

Bluejay Diagnostics completes enrollment in SYMON-II study

Jul 21, 2026, 6:30 AM EDT - 6 weeks ago

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

2026-06-17T21:25:09.000Z - 2 months ago

Bluejay Diagnostics files to sell 11.22M shares of common stock for holders

Jun 5, 2026, 8:13 PM EDT - 3 months ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Jun 2, 2026, 12:19 PM EDT - 3 months ago

Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules

2026-06-02T13:13:16.000Z - 3 months ago

Why Is Penny Stock Bluejay Diagnostics (BJDX) Up Today?

2026-06-02T10:45:59.000Z - 3 months ago

Bluejay Diagnostics, Argonaut Manufacturing Services announce partnership

Jun 2, 2026, 6:30 AM EDT - 3 months ago

Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership

May 7, 2026, 4:01 PM EDT - 4 months ago

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

2026-04-07T10:45:34.000Z - 5 months ago

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

Apr 7, 2026, 6:30 AM EDT - 5 months ago

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Mar 12, 2026, 6:30 AM EDT - 6 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

2026-03-11T13:35:11.000Z - 6 months ago

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

Mar 11, 2026, 9:29 AM EDT - 6 months ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

2026-03-06T11:41:51.000Z - 6 months ago

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

Feb 20, 2026, 6:30 AM EST - 6 months ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

2026-02-17T11:45:15.000Z - 7 months ago

Bluejay Diagnostics enrolls 545 patients in SYMON II study

Feb 17, 2026, 6:30 AM EST - 7 months ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

2026-01-29T00:50:10.000Z - 7 months ago

Bluejay Diagnostics Inc trading halted, news pending

2026-01-27T13:10:41.000Z - 7 months ago

Bluejay Diagnostics announces 1-for-4 reverse stock split

2025-12-29T12:05:14.000Z - 8 months ago

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

Dec 29, 2025, 7:00 AM EST - 8 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

2025-11-10T12:55:58.000Z - 10 months ago

Bluejay Diagnostics provides Q3 corporate update

2025-10-23T21:05:24.000Z - 11 months ago

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

Oct 10, 2025, 5:16 PM EDT - 11 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2025-10-09T19:20:15.000Z - 11 months ago

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

Oct 9, 2025, 3:15 PM EDT - 11 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

2025-10-09T12:11:30.000Z - 11 months ago

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

2025-10-09T10:35:27.000Z - 11 months ago

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Oct 9, 2025, 6:30 AM EDT - 11 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Aug 7, 2025, 6:30 PM EDT - 1 year ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

2025-06-03T20:20:12.000Z - 1 year ago

Bluejay Diagnostics provides corporate update, reduces headcount to five

Jun 3, 2025, 4:05 PM EDT - 1 year ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

2025-04-29T21:35:15.000Z - 1 year ago

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Jun 28, 2024, 11:32 AM EDT - 2 years ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 26, 2024, 8:00 AM EDT - 2 years ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Nov 9, 2023, 4:05 PM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Aug 25, 2023, 8:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 16, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Nov 9, 2022, 8:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Aug 30, 2022, 4:05 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 16, 2022, 7:30 AM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Jul 27, 2022, 7:30 AM EDT - 4 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 26, 2022, 4:30 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Apr 20, 2022, 4:10 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Mar 28, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 24, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 10, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 13, 2022, 11:29 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 5, 2022, 8:15 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Dec 16, 2021, 9:11 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Nov 10, 2021, 8:15 AM EST - 5 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

RichJunkie25 Sep. 1 at 7:06 PM

1 · Reply

the_viking Sep. 1 at 3:28 PM

$BJDX this stock is shorted by 1.19% .... you´re shure about your statement?!

0 · Reply

AtariLynx Aug. 31 at 3:24 PM

$BJDX if it will back to .83 I will add

0 · Reply

Funmoney2 Aug. 31 at 3:07 PM

$BJDX short sellers doing what they can to get rid of their shares and drop the price. Do not panic and do not sell. All a game.. just sit on them and hold

0 · Reply

AtariLynx Aug. 31 at 2:50 PM

$BJDX later

0 · Reply

dogood Aug. 31 at 11:03 AM

$BJDX let’s hit $1.5 today

0 · Reply

xTheEi8htx Aug. 31 at 12:47 AM

Ei8ht Watchlist Next Premarket 7:00–9:00 AM ET $NCT $BRNX $BJDX $NUWE $AEMD

0 · Reply

Ron_Burn Aug. 30 at 8:05 PM

$BJDX the 200-D MA is at 19, fuck it im throwing a 100$ on this tomorrow

0 · Reply

Xen_TorpedoCapital Aug. 30 at 10:10 AM

Top low float watch for Monday $BJDX (PP) $PAVS (BODN) $ERNA (EXP_X) $BSAA (EXP_Y) $NCEW (CON_Y EAP10D 100%+) PFSA (CON_X EAP10D 100%+)

1 · Reply

AtariLynx Aug. 29 at 7:05 AM

0 · Reply

AtariLynx Aug. 28 at 10:46 PM

$BJDX Bluejay Diagnostics (NASDAQ: BJDX) reported Q2 2026 results and operational progress, highlighting advancement of its Symphony™ IL-6 rapid diagnostic platform. The company completed targeted enrollment of 750 hospital patients in its SYMON-II pivotal clinical validation study and is moving into analytical and clinical validation to support a planned FDA 510(k). End of June 26 Armistice Capital Acquires 142,728 Shares of Bluejay Diagnostics Inc (BJDX) at $ 1.20 per share.

0 · Reply

Trendsetta69 Aug. 28 at 10:22 PM

$BJDX this forever will be a bull trap scam company. Trash crook management. Delist soon

0 · Reply

AtariLynx Aug. 28 at 10:19 PM

$BJDX hope above $ 1 next week. Value is so close that it would be a shame to have to do the reverse split.

0 · Reply

PierreleRat Aug. 28 at 9:52 PM

$BJDX how many new bag holders today followed the pumpers saying this was gonna hit $2 😝.

0 · Reply

Almomm0k Aug. 28 at 9:33 PM

$BJDX what happening here?!🥲

0 · Reply

dogood Aug. 28 at 9:24 PM

$BJDX entire day great trading with 4 digit block

0 · Reply

dogood Aug. 28 at 9:01 PM

$BJDX let’s go to $CHAI running again

0 · Reply

AtariLynx Aug. 28 at 8:01 PM

$BJDX ridicolous finale.

0 · Reply

AtariLynx Aug. 28 at 7:47 PM

$BJDX I thought it would close above $ 1.

0 · Reply

dogood Aug. 28 at 6:59 PM

$BJDX lovely 4 digit blocks lol

0 · Reply

PaulR1952 Aug. 28 at 5:46 PM

$BJDX I have been looking for news on this company. What’s going on with their product etc. so far it’s crickets but I did find one interesting article about how they will use their 1 million in assets. It seems to me they have gone on a new path of being aggressive and finding investors. A reverse split, a temporary haunt. It is now up to the CEO and other executives to see if they are scammers or actually want to make this company more then just a joke. This company has some good ideas, some sound investments in what they want to do and now it’s up to the CEO. Does he want to make this company or just try and get rich quick? If he is a scammer he will be blackballed on any project in the future , if he is legit he could be seen as a viable CEO of future deals. It’s going to be interesting this next month to see what this board is. Scammers or Actual good executives with ideas for the future

0 · Reply

dogood Aug. 28 at 5:39 PM

$BJDX it is time for both to run higher $BJDX and $WHLR

1 · Reply

Market Cap	4.02M
Revenue (ttm)	0.00
Net Income (ttm)	-6.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	172,163
Avg Vol	6,080,468
Day's Range	N/A - N/A
Shares Out	4.47M
Stochastic %K	9%
Beta	0.89
Analysts	Strong Buy
Price Target	$32.00